EUSA Pharma hopes IL-6 drug will succeed in COVID-19 where rivals failedUK-based EUSA Pharma has begun a late-stage trial of its antibody siltuximab in COVID-19, hoping that the IL-6 Share XEUSA Pharma hopes IL-6 drug will succeed in COVID-19 where rivals failedhttps://pharmaphorum.com/news/eusa-pharma-hopes-il-6-drug-will-work-in-covid-19-where-class-rivals-failed/
